Therapy Areas: Inflammatory Diseases
Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment
...
Pfizer reports positive Phase 2 results for trispecific antibody in atopic dermatitis
9 March 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) on Monday reported positive topline results from a Phase 2 study evaluating tilrekimig (PF-07275315) in adults with moderate to severe...
Kelun-Biotech and Harbour BioMed receive China IND approval for atopic dermatitis therapy
9 March 2026 - Kelun-Biotech Biopharmaceutical Co, Ltd (6990.HK) announced on Monday that with Harbour BioMed (HKEX: 02142), it has received approval from the National Medical Products Administration ...
Melodia Therapeutics reports award of US patent covering MLD-151
26 February 2026 - Melodia Therapeutics AG, a clinical-stage biotechnology company based in Switzerland, announced on Wednesday that the United States Patent and Trademark Office (USPTO) has granted a...
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
25 February 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) revealed on Wednesday that it has agreed to acquire 35Pharma Inc., a Canada-based clinical-stage biopharmaceutical company, ...
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
...